Treat-to-target and other strategies for optimizing psoriasis patient outcomesShared by:
In 2014, the member states of the World Health Organization (WHO) recognized psoriasis as an important non-communicable disease and the recent release of the WHO Global Report on Psoriasis highlighted its public health impact. At a recent LEO Pharma-sponsored roundtable discussion held during the 22nd Regional Conference of Dermatology (Asian-Australasian) in Singapore, Dr.Colin Theng and Adjunct Associate Professor Chong Wei Sheng from the National Skin Centre, Singapore, and Professor Pravit Asawanonda from Chulalongkorn University, Bangkok, Thailand, discussed this report and suggested possible strategies for improving outcomes for psoriasis patients in Asia. In particular, they highlighted the potential benefits of adopting a treat-to-target approach to psoriasis treatment and discussed the possibility of using strategies such as profiling to improve communication between healthcare professionals and patients.
29 Jul 2016 - General